• Search
  • Advanced Search
Current Issue
Volume 15(2); Dec 2024

Eculizumab Therapy in Neuromyelitis Optica Spectrum Disorder
Jee Eun Kim, Suk-Won Ahn
J Mult Scler Neuroimmunol. 2024;15(2):43-48.

Review Article

Dec 31, 2024
The Clinical Utility of the Ocrelizumab for the Patients with Multiple Sclerorsis
Suk-Won Ahn
J Mult Scler Neuroimmunol. 2024;15(2):49-54.

Review Article

Dec 31, 2024
Summary of Cladribine (from Development to Clinical and Practical Treatment)
Kyong Jin Shin
J Mult Scler Neuroimmunol. 2024;15(2):55-58.

Review Article

Dec 31, 2024
National Consensus Guidance for Management of Refractory Myasthenia Gravis
Hyung-Soo Lee, Hye Yoon Chung, Seung Woo Kim, et al.
J Mult Scler Neuroimmunol. 2024;15(2):59-71.

Original Article

Dec 31, 2024
Temporal Association between Thymoma Recurrence and Exacerbation of Myasthenia Gravis
Byeong Cheol Oh, Ha Young Shin, Young Ho Yang, et al.
J Mult Scler Neuroimmunol. 2024;15(2):72-80.

Original Article

Dec 31, 2024
A Case Report of MOG Antibody-Associated Disease (MOGAD) with Isolated Brainstem and Spinal Cord Involvement
Ye Lin Kim, Juhee Chae, Sun-Young Oh
J Mult Scler Neuroimmunol. 2024;15(2):81-84.

Case Report

Dec 31, 2024
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Presenting as a Diffuse Pachymeningitis
Jun-Soon Kim
J Mult Scler Neuroimmunol. 2024;15(2):85-86.

Neuroimage

Dec 31, 2024

Journal of Multiple
Sclerosis and
Neuroimmunology

Print ISSN: 2733-8290
Online ISSN: 2951-2972

Editorial Office
Department of Neurology, Chung-Ang University Hospital, Chung-Ang University College of Medicine 102, Heukseok-ro, Dongjak-gu, Seoul 06973, Korea
Tel: +82-2-6299-3153   E-mail: icandr@cau.ac.kr                

Copyright © 2025 by Korean Society of Neuroimmunology.

Developed in M2PI